Egypt - angličtina - EDA (Egyptian Drug Authority)

pharma swede - egypt - albendazole 1.2 gm /4gm bolus - bolus

Egypt - angličtina - EDA (Egyptian Drug Authority)

pharma swede - egypt - difloxacin hcl 109 mg ( eq. to difloxacin base 100 mg ) /1ml - oral solution

Egypt - angličtina - EDA (Egyptian Drug Authority)

pharma swede - egypt - ketoprofen 100 mg /1ml - injectable solution

Egypt - angličtina - EDA (Egyptian Drug Authority)

pharma swede - egypt - oxytetracycline hydrochloride 107.93 mg ( eq.to oxytetracycline base 100 mg ) /1ml - injectable solution

Egypt - angličtina - EDA (Egyptian Drug Authority)

pharma swede – egypt. - thiamphenicol 250 mg /1ml - oral solution

Egypt - angličtina - EDA (Egyptian Drug Authority)

pharma swede - egypt - butaphosphan 100 mg + cyanocobalamin 0.05 mg. /1ml - injectable solution

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

pharma-q holdings (pty) ltd - injection - see ingredients - each 1 ml liquid contains epinephrine bitartrate 1,80 mg equivalent to epinephrine 1 mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - gabapentin, quantity: 100 mg - capsule, hard - excipient ingredients: lactose; purified talc; maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.